Newvast (atorvastatin strontium pentahydrate)
/ Hanmi
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 26, 2022
An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
(clinicaltrials.gov)
- P=N/A | N=1716 | Completed | Sponsor: Hanmi Pharmaceutical Company Limited
New trial • Dyslipidemia • Metabolic Disorders
1 to 1
Of
1
Go to page
1